|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glaucoma
The second leading cause of blindness among Americans is glaucoma. An estimated 3 million Americans age 40 and over have glaucoma, and it affects 3% of people age 65 and over. Studies show that glaucoma is three to four times more likely to occur in African Americans and about six times more likely to cause blindness in blacks than in whites. Glaucoma is a painless eye disorder that occurs when pressure (ocular
hypertension) builds up within the eye because of resistance to aqueous
humor outflow from the chamber of the eye. It causes a insidious and
progressive loss of vision as the optic nerve and retina are damaged.
Central visual acuity can remain normal for a long time while vision
in the peripheral field gradually constricts.
Risk Factors for Glaucoma The goal of medical treatment is to lower intraocular pressure. Until recently, the medical treatment of glaucoma required using as many as four eye drops, plus oral medications. Often effective control was not achieved and patients continued to lose their vision. Moreover, these drugs had numerous visual and systemic side effects such as low blood pressure, confusion, or anorexia which may be especially serious for older adults. Lastly, the use of glaucoma medications required strict compliance and the regime of multiple medications and side effects were often problematic. Fortunately, laser treatment has become the primary approach to treatment.
The National Eye Institute has found that early use of laser surgery
is at least as effective and has fewer side effects than the long-term
use of eye drops. Argon laser trabeculoplasty (ALT) relieves pressure
by creating drainage holes in the eye's filtering area. Prevention The best way to detect glaucoma is to see an eye specialist who uses a combination of tonometry (e.g., air puff test) and direct opthalmoscopy through dilated pupils. Tonometry is a screening test used to check intraocular pressure (IOP) and detect glaucoma. High risk adults should have a complete visual exam with dilation of the eye every 1 to 2 years, and all adults over age 40 should have a screening examination every 3 years to check for cupping of the optic nerve evacuation and a visual field exam to identify any visual field defects.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||